Key facts
- Oxford Endovascular’s last known valuation is $36.8M.
- It has raised $25.7M; the latest was Later Stage VC ($10.0M) in May 2024.
- Notable investors include Innovate UK, Parkwalk Advisors, University of Oxford, Oxford Science Enterprises, Perivoli Innovations — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Oxford Endovascular
- ·The full record, as it builds
Funding rounds
No funding rounds for Oxford Endovascular are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oxford Endovascular
Developer of a neurovascular disease device designed to treat brain aneurysms. The company's device uses origami engineering to prepare a laser-cut metal alloy that can be inserted into a patient's brain using a catheter where it expands to a tiny mesh tube that takes the shape of the blood vessel for diverting blood flow away from intracranial aneurysms at risk of rupture, enabling healthcare practitioners to treat patients suffering from brain aneurysms with good survival rates by reducing the risk of adverse events.
- Sector
- Healthcare
- HQ
- Oxford, United Kingdom
- Founded
- 2015
- Employees
- 9
- Website
- oxfordendovascular.com/
- Ownership
- Privately Held (backing)
Oxford Endovascular doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oxford Endovascular shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oxford Endovascular in its N-PORT filings yet. We sweep new filings monthly.